Stockscreener 앱 받기
0.2757
0.68%
-0.0019
시간 외 거래:
.29
0.0143
+5.19%
전일 마감가:
$0.2776
열려 있는:
$0.2777
하루 거래량:
1.06M
Relative Volume:
0.93
시가총액:
$27.60M
수익:
$1.27M
순이익/손실:
$-7.12M
주가수익비율:
-5.2816
EPS:
-0.0522
순현금흐름:
$-5.28M
1주 성능:
-1.89%
1개월 성능:
-3.60%
6개월 성능:
-16.07%
1년 성능:
-8.10%
1일 변동 폭
$0.275
$0.2856
1주일 범위
$0.275
$0.2977
52주 변동 폭
$0.242
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
명칭
IGC Pharma Inc
전화
301-983-0998
주소
4336 Montgomery Avenue, Bethesda, MD
Compare IGC vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.2757 | 28.07M | 1.27M | -7.12M | -5.28M | -0.0522 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
IGC Pharma Inc 주식(IGC)의 최신 뉴스
IGC Reaches Enrollment Milestone in Alzheimer's Dementia Trial - GuruFocus
IGC Pharma (NYSE American: IGC) Alzheimer's Drug Gains Attention After Ascendiant Capital Raises Price Target - openPR.com
IGC Pharma (IGC) Inches Up 1.78% as It Approaches Key ResistanceSwing Entry Signals - newsline.com
Agitation in Alzheimer's Disease Market to Register Immense Growth at a CAGR of 14.9% During the Forecast Period (2026-2036) | DelveInsight - 富途牛牛
IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis - The Daily Corinthian
Alzheimer's agitation drug study nears final data as IGC enrolls 146 patients - Stock Titan
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts - BioSpace
IGC Maintained by Ascendiant Capital -- Price Target Raised to $5.50 - GuruFocus
IGC Pharma Extends and Amends $12 Million Loan Facility - TipRanks
IGC Pharma Extends $12 Million O-Bank Credit Facility; Increases Fee to $60,000 - TradingView
IGC Pharma (NYSE: IGC) extends $12M O-Bank loan facility with higher fee - Stock Titan
IGC Pharma, Inc. Enters Into Amendment To Extend Master Loan And Security Agreement With O-Bank Co., Ltd - marketscreener.com
Listed NanoCaps: PMI, IGC, WTC, WOK, SELX Radar Stocks to Watch Now! - openPR.com
Stocks to Watch: ANY, CMND, PRFX, OLOX, IGC Data Centers, AI, Quantum & Healthcare - FinancialContent
IGC Pharma Adds Mount Sinai Clinical Site as CALMA Trial Advances Toward Completion and Topline Analysis - Black Hills Pioneer
IGC Technical Analysis | Trend, Signals & Chart Patterns | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
IGC Pharma Expands CALMA Trial with New Site at Mount Sinai - GuruFocus
IGC Pharma Adds Mount Sinai as CALMA Trial Nears Readout - ACCESS Newswire
IGC Pharma's (NYSE: IGC) CEO Appears on Bloomberg TV Discussing - openPR.com
IGC Pharma’s (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer’s Fast-Acting IGC-AD1 Pharmaceutical Therapeutic – More Stocks Inside - Barchart.com
New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medi - Newswire.com
IGC Pharma Holds Steady at $0.29 as Stock Consolidates Near Key LevelsMoney Flow - The Legal Advocate
IGC Q1 2026 Earnings: Narrowing Losses on Lower Expenses as EPS Surprises to the UpsideEarnings Volatility Report - newsline.com
Alzheimer's AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in FocusMore Stocks Inside - openPR.com
Alzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside - Carroll County Mirror-Democrat
Daily Penny AlertsAlzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside - FinancialContent
IGC Pharma (IGC) Hovers Near Support After Modest Gain, Awaiting BreakoutETF NAV Deviation - newsline.com
IGC Q1 2026 Earnings: EPS Surpasses Estimates by 14.16% Amid Revenue ChallengesEarnings Revision Report - The Legal Advocate
IGC Pharma Q1 2026 Earnings: Narrower Loss Beats Estimates; Shares Edge LowerTrading Community - Newser
IGC Q1 2026 Earnings: Narrowing Losses as Cost Discipline Drives EPS BeatEarnings Power Value - newsline.com
IGC Pharma earnings beat, revenue topped estimates By Investing.com - Investing.com Australia
IGC Pharma (IGC) Q1 2026 Earnings: $-0.02 EPS Surges Past $-0.02 EstimatesEstimate Revision Count - Newser
IGC Pharma (IGC) Delivers Q1 2026 Beat — EPS $-0.02 vs $-0.02 ExpectedForward EPS Estimate - Newser
IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment - BioSpace
IGC Pharma (IGC) Q1 2026 Earnings Surprise: EPS $-0.02, Up SignificantPopular Trader Picks - Newser
IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference - Black Hills Pioneer
IGC Pharma, Inc. Common Stock (NY: IGC - The Chronicle-Journal
IGC Pharma (NYSE: IGC) deepens Alzheimer’s R&D amid tight cash and new loans - Stock Titan
IGC Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
IGC Unveils Tau-PET Biomarker Study for Alzheimer's at Global Ta - GuruFocus
IGC Pharma Inc (IGC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
IGC Pharma Inc 주식 (IGC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mukunda Ram | CEO |
Apr 01 '26 |
Option Exercise |
0.13 |
656,410 |
84,000 |
4,649,088 |
| Mukunda Ram | CEO |
Apr 01 '26 |
Option Exercise |
0.00 |
49,999 |
0 |
910,751 |
| Moran James P | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
130,000 |
0 |
1,235,735 |
| GRIMALDI CLAUDIA | PFO |
Apr 01 '26 |
Option Exercise |
0.15 |
238,462 |
36,000 |
1,372,714 |
| Mukunda Ram | CEO |
Feb 03 '26 |
Option Exercise |
0.00 |
50,000 |
0 |
860,752 |
| PRINS RICHARD K | Director |
Jan 19 '26 |
Option Exercise |
0.00 |
100,000 |
0 |
1,371,251 |
2.60%
0.94%
자본화:
|
볼륨(24시간):